Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in mice

Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in mice

Current vaccines against SARS-CoV-2 reduce mortality but are less effective in preventing infection. Here the authors show that intranasal vaccination with a subunit vaccine including an TLR2-stimulating adjuvant induces strong neutralising antibody and T-cell responses against SARS-CoV-2 in the lun...

Full description

Bibliographic Details
Main Authors:	Anneliese S. Ashhurst, Matt D. Johansen, Joshua W. C. Maxwell, Skye Stockdale, Caroline L. Ashley, Anupriya Aggarwal, Rezwan Siddiquee, Stefan Miemczyk, Duc H. Nguyen, Joel P. Mackay, Claudio Counoupas, Scott N. Byrne, Stuart Turville, Megan Steain, James A. Triccas, Philip M. Hansbro, Richard J. Payne, Warwick J. Britton
Format:	Article
Language:	English
Published:	Nature Portfolio 2022-11-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-022-34297-3

Similar Items

Discovery of Cyclic Peptide Ligands to the SARS-CoV‑2 Spike Protein Using mRNA Display
by: Alexander Norman, et al.
Published: (2021-05-01)

A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection
by: Claudio Counoupas, et al.
Published: (2021-11-01)

Deciphering protective immunity against tuberculosis: implications for vaccine development
by: Claudio Counoupas, et al.
Published: (2019-04-01)

Immunogenicity and Protective Efficacy of a Multi-Antigen <i>Mycobacterium tuberculosis</i> Subunit Vaccine in Mice
by: Annuurun Nisa, et al.
Published: (2024-08-01)

Characterization of the Protective Immune Responses Conferred by Recombinant BCG Overexpressing Components of <i>Mycobacterium tuberculosis</i> Sec Protein Export System
by: Annuurun Nisa, et al.
Published: (2022-06-01)

Delta inulin-based adjuvants promote the generation of polyfunctional CD4+ T cell responses and protection against Mycobacterium tuberculosis infection
by: Claudio Counoupas, et al.
Published: (2017-08-01)

An LNP-mRNA vaccine modulates innate cell trafficking and promotes polyfunctional Th1 CD4+ T cell responses to enhance BCG-induced protective immunity against Mycobacterium tuberculosisResearch in context
by: Hannah Lukeman, et al.
Published: (2025-03-01)

High-Titer Neutralizing Antibodies against the SARS-CoV-2 Delta Variant Induced by Alhydroxyquim-II-Adjuvanted Trimeric Spike Antigens
by: Claudio Counoupas, et al.
Published: (2022-02-01)

L-selectin-dependent and -independent homing of naïve lymphocytes through the lung draining lymph node support T cell response to pulmonary Mycobacterium tuberculosis infection.
by: Lina Daniel, et al.
Published: (2023-07-01)

Lung IL-17A-Producing CD4<sup>+</sup> T Cells Correlate with Protection after Intrapulmonary Vaccination with Differentially Adjuvanted Tuberculosis Vaccines
by: Erica L. Stewart, et al.
Published: (2024-01-01)

Stromal structure remodeling by B lymphocytes limits T cell activation in lymph nodes of Mycobacterium tuberculosis–infected mice
by: Lina Daniel, et al.
Published: (2022-11-01)

A unique cytotoxic CD4+ T cell‐signature defines critical COVID‐19
by: Sarah Baird, et al.
Published: (2023-01-01)

TLR2, TLR4 AND MyD88 Mediate Allergic Airway Disease (AAD) and Streptococcus pneumoniae-Induced Suppression of AAD.
by: Alison N Thorburn, et al.
Published: (2016-01-01)

CXCR6-Deficiency Improves the Control of Pulmonary Mycobacterium tuberculosis and Influenza Infection Independent of T-Lymphocyte Recruitment to the Lungs
by: Anneliese S. Ashhurst, et al.
Published: (2019-03-01)

Cell-free Synthesis of Correctly Folded Proteins with Multiple Disulphide Bonds: Production of Fungal Hydrophobins
by: Rezwan Siddiquee, et al.
Published: (2021-05-01)

Clinical and Experimental Determination of Protection Afforded by BCG Vaccination against Infection with Non-Tuberculous Mycobacteria: A Role in Cystic Fibrosis?
by: Sherridan Warner, et al.
Published: (2023-08-01)

PLGA particulate subunit tuberculosis vaccines promote humoral and Th17 responses but do not enhance control of Mycobacterium tuberculosis infection.
by: Anneliese S Ashhurst, et al.
Published: (2018-01-01)

Embedding of HIV Egress within Cortical F-Actin
by: Anupriya Aggarwal, et al.
Published: (2022-01-01)

An Agenda for Sustainable Operations and Supply Chain Management Research
by: Joe Miemczyk
Published: (2013-08-01)

CXCR3 Provides a Competitive Advantage for Retention of <i>Mycobacterium tuberculosis</i>-Specific Tissue-Resident Memory T Cells Following a Mucosal Tuberculosis Vaccine
by: Ellis Armitage, et al.
Published: (2023-09-01)

No smoke without fire: the impact of cigarette smoking on the immune control of tuberculosis
by: Diana H. Quan, et al.
Published: (2022-06-01)

Varicella zoster virus productively infects human natural killer cells and manipulates phenotype.
by: Tessa Mollie Campbell, et al.
Published: (2018-04-01)

Mobilization of HIV spread by diaphanous 2 dependent filopodia in infected dendritic cells.
by: Anupriya Aggarwal, et al.
Published: (2012-01-01)

The Role of TLR2, TLR4, and TLR9 in the Pathogenesis of Atherosclerosis
by: Mohsin H. K. Roshan, et al.
Published: (2016-01-01)

Bivalent Omicron BA.1 vaccine booster increases memory B cell breadth and neutralising antibodies against emerging SARS-CoV-2 variantsResearch in context
by: Lok Bahadur Shrestha, et al.
Published: (2024-12-01)

The secreted lipoprotein, MPT83, of Mycobacterium tuberculosis is recognized during human tuberculosis and stimulates protective immunity in mice.
by: Fan F Kao, et al.
Published: (2012-01-01)

Fibroblast-expressed LRRC15 is a receptor for SARS-CoV-2 spike and controls antiviral and antifibrotic transcriptional programs
by: Lipin Loo, et al.
Published: (2023-02-01)

Fibroblast-expressed LRRC15 is a receptor for SARS-CoV-2 spike and controls antiviral and antifibrotic transcriptional programs.
by: Lipin Loo, et al.
Published: (2023-02-01)

TLR2 and TLR4 in Ischemia Reperfusion Injury
by: F. Arslan, et al.
Published: (2010-01-01)

Expression of TLR2, TLR3, TLR4, and TLR7 on pulmonary lymphocytes of -infected C57BL/6 mice
by: Dianhui Chen, et al.
Published: (2019-05-01)

Influence of Age, Past Smoking, and Disease Severity on TLR2, Neutrophilic Inflammation, and MMP-9 Levels in COPD
by: Jodie L. Simpson, et al.
Published: (2013-01-01)

TLR9- and TLR7-enhanced CD8(+) T cell responses are suppressed by TLR2-ligands
by: Schwarz, K, et al.
Published: (2007)

Protein Expression of TLR2, TLR4, and TLR9 on Monocytes in TB, HIV, and TB/HIV
by: Wegene Tamene, et al.
Published: (2024-01-01)

Boosting BCG with recombinant influenza A virus tuberculosis vaccines increases pulmonary T cell responses but not protection against Mycobacterium tuberculosis infection
by: Heni Muflihah, et al.
Published: (2021-01-01)

Boosting BCG with recombinant influenza A virus tuberculosis vaccines increases pulmonary T cell responses but not protection against Mycobacterium tuberculosis infection.
by: Heni Muflihah, et al.
Published: (2021-01-01)

Functional Interplay between Type I and II Interferons Is Essential to Limit Influenza A Virus-Induced Tissue Inflammation.
by: Sebastian A Stifter, et al.
Published: (2016-01-01)

Generation of anti-TLR2 intrabody mediating inhibition of macrophage surface TLR2 expression and TLR2-driven cell activation
by: Lindenmaier Werner, et al.
Published: (2010-04-01)

Basophil activation through TLR2 and TLR4 signaling pathways
by: Manal Alkan, et al.
Published: (2018-08-01)

Using of TLR2 and TLR4 as Biomarker of Sepsis Severity Detection
by: Farah Qahtan Younis, et al.
Published: (2018-11-01)

The Expression of TLR2 and TLR3 in Sertoli Cells of Azoospermic Patients
by: Mohammad Reza Lakpour, et al.
Published: (2017-08-01)